Skip to main content
PMC home page
Heart logoLink to Heart
. 2001 Jun;85(6):662–666. doi: 10.1136/heart.85.6.662

Outcomes following coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in the stent era: a prospective study of all 9890 consecutive patients operated on in Scotland over a two year period

J Pell 1, D Walsh 1, J Norrie 1, G Berg 1, A Colquhoun 1, K Davidson 1, H Eteiba 1, A Faichney 1, A Flapan 1, K Hogg 1, R Jeffrey 1, K Jennings 1, J McArthur 1, P Mankad 1, K Oldroyd 1, A Pell 1, I Starkey 1
PMCID: PMC1729765  PMID: 11359748

Abstract

OBJECTIVE—To determine current outcomes of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG).
DESIGN—The Scottish coronary revascularisation register provided prospectively collected data on case mix and in-hospital complications for all revascularisation procedures between April 1997 and March 1999 (4775 PTCA; 5115 CABG). Linkage to routine hospital discharge and death data provided follow up information on survival and repeat revascularisation.
RESULTS—Stents were used in 51% of PTCA procedures. CABG patients were older, had more severe coronary disease, and had greater comorbidity. PTCA was more likely to be undertaken as an urgent or emergency procedure. Perioperative death and urgent surgery followed 0.3% and 0.6% of PTCA procedures, respectively. Case fatality rates were higher following CABG, with 6.7% dead within two years compared with 3.4% following PTCA. PTCA was more often followed by readmission for ischaemic heart disease, repeat angiography, or revascularisation: 22.8% of patients had repeat revascularisation within two years, compared with 1.8% following CABG.
CONCLUSIONS—The severity of coronary heart disease was greater than in previously published registry studies and randomised trials. Despite this, overall survival figures were comparable and repeat revascularisation rates lower, particularly following PTCA. Perioperative death and urgent surgery following PTCA were also lower. These favourable outcomes may be attributable, in part, to increased use of bail out and elective stenting.


Keywords: percutaneous transluminal coronary angioplasty; coronary artery bypass grafting; survival; outcome

Full Text

The Full Text of this article is available as a PDF (116.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betriu A., Masotti M., Serra A., Alonso J., Fernández-Avilés F., Gimeno F., Colman T., Zueco J., Delcan J. L., García E. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. J Am Coll Cardiol. 1999 Nov 1;34(5):1498–1506. doi: 10.1016/s0735-1097(99)00366-6. [DOI] [PubMed] [Google Scholar]
  2. Detre K. M., Guo P., Holubkov R., Califf R. M., Sopko G., Bach R., Brooks M. M., Bourassa M. G., Shemin R. J., Rosen A. D. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). Circulation. 1999 Feb 9;99(5):633–640. doi: 10.1161/01.cir.99.5.633. [DOI] [PubMed] [Google Scholar]
  3. Gum P. A., O'Keefe J. H., Jr, Borkon A. M., Spertus J. A., Bateman T. M., McGraw J. P., Sherwani K., Vacek J., McCallister B. D. Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients. Circulation. 1997 Nov 4;96(9 Suppl):II–7-10. [PubMed] [Google Scholar]
  4. Hamm C. W., Reimers J., Ischinger T., Rupprecht H. J., Berger J., Bleifeld W. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) N Engl J Med. 1994 Oct 20;331(16):1037–1043. doi: 10.1056/NEJM199410203311601. [DOI] [PubMed] [Google Scholar]
  5. Hannan E. L., Racz M. J., McCallister B. D., Ryan T. J., Arani D. T., Isom O. W., Jones R. H. A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1999 Jan;33(1):63–72. doi: 10.1016/s0735-1097(98)00540-3. [DOI] [PubMed] [Google Scholar]
  6. Henderson R. A., Pocock S. J., Sharp S. J., Nanchahal K., Sculpher M. J., Buxton M. J., Hampton J. R. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet. 1998 Oct 31;352(9138):1419–1425. doi: 10.1016/s0140-6736(98)03358-3. [DOI] [PubMed] [Google Scholar]
  7. Jones R. H., Kesler K., Phillips H. R., 3rd, Mark D. B., Smith P. K., Nelson C. L., Newman M. F., Reves J. G., Anderson R. W., Califf R. M. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg. 1996 May;111(5):1013–1025. doi: 10.1016/s0022-5223(96)70378-1. [DOI] [PubMed] [Google Scholar]
  8. King S. B., 3rd, Kosinski A. S., Guyton R. A., Lembo N. J., Weintraub W. S. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST) J Am Coll Cardiol. 2000 Apr;35(5):1116–1121. doi: 10.1016/s0735-1097(00)00546-5. [DOI] [PubMed] [Google Scholar]
  9. King S. B., 3rd, Lembo N. J., Weintraub W. S., Kosinski A. S., Barnhart H. X., Kutner M. H., Alazraki N. P., Guyton R. A., Zhao X. Q. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST) N Engl J Med. 1994 Oct 20;331(16):1044–1050. doi: 10.1056/NEJM199410203311602. [DOI] [PubMed] [Google Scholar]
  10. Lee H. S., Densem C., Levy R. D., Bennett D. H., Ray S. G., Brooks N. H. Impact of stenting on coronary angioplasty procedures. Heart. 1998 Nov;80(5):505–508. doi: 10.1136/hrt.80.5.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Macaya C., Serruys P. W., Ruygrok P., Suryapranata H., Mast G., Klugmann S., Urban P., den Heijer P., Koch K., Simon R. Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group. J Am Coll Cardiol. 1996 Feb;27(2):255–261. doi: 10.1016/0735-1097(95)00473-4. [DOI] [PubMed] [Google Scholar]
  12. Rodriguez A., Mele E., Peyregne E., Bullon F., Perez-Baliño N., Liprandi M. I., Palacios I. F. Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI). J Am Coll Cardiol. 1996 Apr;27(5):1178–1184. doi: 10.1016/0735-1097(95)00592-7. [DOI] [PubMed] [Google Scholar]
  13. Serruys P. W., Unger F., van Hout B. A., van den Brand M. J., van Herwerden L. A., van Es G. A., Bonnier J. J., Simon R., Cremer J., Colombo A. The ARTS study (Arterial Revascularization Therapies Study). Semin Interv Cardiol. 1999 Dec;4(4):209–219. doi: 10.1006/siic.1999.0107. [DOI] [PubMed] [Google Scholar]
  14. Stables R. H. Design of the 'Stent or Surgery' trial (SoS): a randomized controlled trial to compare coronary artery bypass grafting with percutaneous transluminal coronary angioplasty and primary stent implantation in patients with multi-vessel coronary artery disease. Semin Interv Cardiol. 1999 Dec;4(4):201–207. doi: 10.1006/siic.1999.0101. [DOI] [PubMed] [Google Scholar]
  15. Ugnat A. M., Naylor C. D. Trends in coronary artery bypass grafting in Ontario from 1981 to 1989. CMAJ. 1993 Feb 15;148(4):569–575. [PMC free article] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES